MOSCOW (Reuters) - Russia took a step towards clamping down on the tobacco industry on Friday as a bill to ban smoking in public spaces and to restrict tobacco sales sailed through its first reading in parliament.
NEW YORK (Reuters Health) - Migraine patients have an increased risk of idiopathic sudden sensorineural hearing loss (SSNHL), a study from Taiwan suggests.
NEW YORK (Reuters Health) - The presence in plasma of sTREM-1 (soluble triggering receptor expressed on myeloid cells-1) had only "moderate" diagnostic performance in differentiating sepsis from systemic inflammatory response syndrome (SIRS) in a meta-analysis of relevant research.
NEW YORK (Reuters Health) - For patients with migraine and irritable bowel syndrome (IBS), an immunoglobulin G (IgG)-based food elimination diet may effectively reduce symptoms of both disorders, a small Turkish study suggests.
WASHINGTON (Reuters) - Only 15 U.S. states plan to operate health insurance exchanges under President Barack Obama's reform law, leaving Washington with the daunting prospect of creating and operating the new online marketplaces in at least two-thirds of the country.
NEW YORK (Reuters Health) - Fish oil supplements may be ineffective against the chronic intestinal damage found in infants in developing regions, a new study suggests.
NEW YORK (Reuters Health) - The new phosphodiesterase type 5 (PDE5) inhibitor avanafil (Stendra) was safe and significantly more effective than placebo in reversing erectile dysfunction (ED) after bilateral nerve-sparing radical prostatectomy in a recent trial.
NEW YORK (Reuters Health) - Added to standard CHOP chemotherapy, both rituximab and radioimmunotherapy (RIT) produce excellent results in patients presenting with advanced follicular lymphoma, a Southwest Oncology Group study shows.
Lilly research chief Jan Lundberg, in an interview with Reuters last week, predicted the company will do for Alzheimer's patients what it did almost a century ago for diabetics - find a breakthrough treatment, even though skeptics say it could take years.